Aging-associated Diseases Codexery

Dopamine dysregulation syndrome

In individuals undergoing extended dopaminergic pharmacotherapy, a rare condition known as dopamine dysregulation syndrome (DDS) can emerge, characterized by a malfunction within the brain's reward circuitry.[1] This condition manifests through markedly uninhibited actions, including compulsive gambling, hypersexuality, and an addictive pattern toward the prescribed medication.[1] Extended use of dopamine agonists in patients diagnosed with either Parkinson's disease or restless legs syndrome is the typical context for this syndrome's development.[1]

Quick Facts

Specialty
Neurology, Psychiatry
Complications
  • Psychosis
  • addiction
  • marital problems
  • financial problems
Causes
Dopaminergic drugs (e.g., dopamine agonists, levodopa)
Treatment
Reduce intake of dopaminergic drug
Medication
Antipsychotics, valproate

Facts from the source article.

Key facts and history

Hypomania with euphoria or grandiosity can occur at peak medication effects, while dysphoria with sadness or fatigue is typical during withdrawal.[2] DDS is not common among Parkinson's disease patients, with prevalence around 4%.[3] This craving constitutes a powerful urge to acquire the medicine even when no symptoms warrant its use, prompting the individual to take additional, unscheduled doses.[2] Should the person be unable to self-administer extra medication, they may exhibit aggressive outbursts or employ tactics like feigning symptoms or offering bribes to obtain it.[4]

Levodopa or dopamine agonists are the primary agents used in dopamine replacement therapy, the standard treatment approach.[5] Levodopa is the drug most frequently associated with the onset of DDS.[6] The syndrome now known as DDS was initially characterized as a distinct clinical entity in the year 2000.[7]

What the research sources say

A 2017 systematic review found that 88% of 98 DDS cases in Parkinson's disease patients were related to levodopa, with remaining cases due to apomorphine, pramipexole, rotigotine, ropinirole, and piribedil.[6] A 2019 systematic review of DDS in non-Parkinson's patients found levodopa implicated in 11 of 14 cases (79%), with the remainder linked to pramipexole, ropinirole, and talipexole.[6] A case report documented that the levodopa-containing herbal supplement Mucuna pruriens can also trigger DDS.[6]

References

  1. Wikipedia, "Dopamine dysregulation syndrome" (CC BY-SA 4.0), which cites: Grall-Bronnec, "Dopamine Agonists and Impulse Control Disorders: A Complex Association", Drug Safety, August 31, 2017, p. 19–75; Klepitskaya, "Encyclopedia of Movement Disorders", 2010, p. 323–326; "Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease", Parkinsonism Relat. Disord., 2008, p. 273–80; "Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease", Parkinsonism Relat. Disord., 2008, p. 273–80 (we also read that source) en.wikipedia.org
  2. Wikipedia, "Dopamine dysregulation syndrome" (CC BY-SA 4.0), which cites: "Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?", Lancet Neurol, October 2003, p. 595–604; "Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?", Lancet Neurol, October 2003, p. 595–604 (original not read by us) en.wikipedia.org
  3. Wikipedia, "Dopamine dysregulation syndrome" (CC BY-SA 4.0), which cites: "Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease", Parkinsonism Relat. Disord., 2008, p. 273–80; "Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease", Mov. Disord., January 2005, p. 77–81; "Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?", Lancet Neurol, October 2003, p. 595–604; "Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?", Lancet Neu en.wikipedia.org
  4. Wikipedia, "Dopamine dysregulation syndrome" (CC BY-SA 4.0), which cites: "Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?", Lancet Neurol, October 2003, p. 595–604 (original not read by us) en.wikipedia.org
  5. Wikipedia, "Dopamine dysregulation syndrome" (CC BY-SA 4.0), which cites: Cools R, "Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease", Neurosci Biobehav Rev, 2006, p. 1–23; "Dopamine dysregulation syndrome in Parkinson's disease", Curr. Opin. Neurol., August 2004, p. 393–8; "Dopamine dysregulation syndrome in Parkinson's disease", Curr. Opin. Neurol., August 2004, p. 393–8; "Dopamine dysregulation syndrome in Parkinson's disease", Curr. Opin. Neurol., August 2004, p. 393–8; "Compulsive use of dopamine replacement therapy in Parkinson's dise en.wikipedia.org
  6. Wikipedia, "Dopamine dysregulation syndrome" (CC BY-SA 4.0), which cites: "Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases", J Neurol Neurosurg Psychiatry, December 2017, p. 1060–1064; "Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases", J Neurol Neurosurg Psychiatry, December 2017, p. 1060–1064; "Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases", J Neurol Neurosurg Psychiatry, December 2017, p. 1060–1064; "Dopamine dysregulation syndrome in non-Parkinson's en.wikipedia.org
  7. Wikipedia, "Dopamine dysregulation syndrome" (CC BY-SA 4.0), which cites: Parkinson J, "An essay on the shaking palsy", J Neuropsychiatry Clin Neurosci, 2002, p. 223–36; discussion 222; Cotzias GC, "L-Dopa for Parkinsonism", N. Engl. J. Med., March 1968, p. 630; "Treatment of parkinsonism with levodopa", Arch. Neurol., October 1969, p. 343–54; "Treatment of parkinsonism with levodopa", Arch. Neurol., October 1969, p. 343–54; "Punding on L-dopa", Mov. Disord., September 1999, p. 836–8; "Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease", Pharmacopsychiatria, July 198 en.wikipedia.org

Each numbered sentence above was checked against the source it cites before publication. Sentences citing Wikipedia adapt text from the English Wikipedia article Dopamine dysregulation syndrome (contributors), used under CC BY-SA 4.0; this entry is available under the same licence. Other sources were used for facts only; no text or images are copied from them.

More in Aging-associated diseases

Spotted an error? Know more?

Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced

Comments

Loading…
Open in the interactive codex →